ATC Group: C10BA06 Rosuvastatin and ezetimibe

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C10BA06 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C10 Lipid modifying agents
3 C10B Lipid modifying agents, combinations
4 C10BA Combinations of various lipid modifying agents
5 C10BA06

Related product monographs

Title Information Source Document Type  
EZEHRON DUO Tablet Medicines Authority (MT) MPI, EU: SmPC
TWICOR Film-coated tablet Medicines Authority (MT) MPI, EU: SmPC

Medicines in this ATC group

Australia (AU)

Austria (AT)

Brazil (BR)

Croatia (HR)

Ecuador (EC)

Estonia (EE)

France (FR)

Germany (DE)

Ireland (IE)

Italy (IT)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

Poland (PL)

Romania (RO)

Spain (ES)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.